Trial Profile
Pharmacokinetics and Safety of Single and Multiple doses of Intravenous (IV) Lascufloxacin in healthy male subjects: Phase I study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Oct 2016
Price :
$35
*
At a glance
- Drugs Lascufloxacin (Primary)
- Indications Community-acquired pneumonia; Otorhinolaryngological infections; Respiratory tract infections
- Focus Adverse reactions; Pharmacokinetics
- 03 Oct 2016 New trial record